Through the use of western blot analysis, we found that, compared with those in control cells, the protein levels of FoxO3 and phospho-FoxO3 in MCF-7 or MDA-MB-231 breast cancer cells were dramatically lower in the JNKi-treated cells (Figure 4D,E). This evidence concerns the gene FOXO3 and breast carcinoma.